DNA (STOCKS)
Ginkgo Bioworks Holdings, Inc.
$8.100000
+0.210000 (+2.66%)
Prev close: $7.890000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Jason Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $537.62M
- Employees
- 834
- P/E (TTM)
- -1.46
- P/B (TTM)
- 1.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $141.31M |
| Benefits Costs and Expenses | $440.18M |
| Costs And Expenses | $435.42M |
| Operating Expenses | $435.90M |
| Depreciation and Amortization | $56.97M |
| Research and Development | $222.77M |
| Other Operating Expenses | $186.67M |
| Operating Income/Loss | -$297.68M |
| Income/Loss From Continuing Operations After Tax | -$297.87M |
| Income/Loss From Continuing Operations Before Tax | -$298.87M |
| Income Tax Expense/Benefit | -$1.01M |
| Net Income/Loss | -$304.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$304.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$304.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.36 |
| Basic Average Shares | 170,597,291 |
| Assets | $1.03B |
| Current Assets | $409.96M |
| Noncurrent Assets | $623.12M |
| Fixed Assets | $163.02M |
| Intangible Assets | $48.86M |
| Other Non-current Assets | $411.24M |
| Liabilities | $589.92M |
| Current Liabilities | $79.60M |
| Accounts Payable | $16.31M |
| Other Current Liabilities | $63.29M |
| Noncurrent Liabilities | $510.33M |
| Equity | $443.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $443.15M |
| Liabilities And Equity | $1.03B |
| Net Cash Flow From Operating Activities | -$166.22M |
| Net Cash Flow From Operating Activities, Continuing | -$174.74M |
| Net Cash Flow From Investing Activities | -$18.47M |
| Net Cash Flow From Investing Activities, Continuing | -$18.47M |
| Net Cash Flow From Financing Activities | $17.96M |
| Net Cash Flow From Financing Activities, Continuing | $17.96M |
| Exchange Gains/Losses | -$2.00K |
| Net Cash Flow | -$166.74M |
| Net Cash Flow, Continuing | -$175.25M |
| Comprehensive Income/Loss | -$302.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$302.35M |
| Other Comprehensive Income/Loss | $2.04M |